Cargando…

Anticoagulation in COVID-19: It Is Time for High-Quality Evidence

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Lopes, Renato D., Fanaroff, Alexander C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American College of Cardiology Foundation. Published by Elsevier. 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550042/ https://www.ncbi.nlm.nih.gov/pubmed/33059827 http://dx.doi.org/10.1016/j.jacc.2020.09.008

Ejemplares similares

Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease
por: Fanaroff, Alexander C, et al.
Publicado: (2022)

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
por: Nadkarni, Girish N., et al.
Publicado: (2020)

Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19
por: Vaughn, Valerie M., et al.
Publicado: (2021)

Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
por: Stone, Gregg W., et al.
Publicado: (2023)

Frailty, Home Time, and Health Care Costs in Older Adults With Atrial Fibrillation Receiving Oral Anticoagulants
por: Lin, Kueiyu Joshua, et al.
Publicado: (2023)

Time Trends in Patient Characteristics, Anticoagulation Treatment, and Prognosis of Incident Nonvalvular Atrial Fibrillation in the Netherlands
por: Chen, Qingui, et al.
Publicado: (2023)

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
por: Lip, Gregory Y. H., et al.
Publicado: (2021)

Patients and Their Physician’s Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant
por: Cannon, Christopher P., et al.
Publicado: (2023)

Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials
por: Hijazi, Ziad, et al.
Publicado: (2020)

Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

Analysis of Anticoagulation Therapy and Anticoagulation-Related Outcomes Among Asian Patients After Mechanical Valve Replacement
por: Huang, Jo-Ting, et al.
Publicado: (2022)

High-Sensitivity Troponin in Patients With Cancer: Sensitive But Not Specific
por: Fanaroff, Alexander C., et al.
Publicado: (2023)

Commentary on the 2021 ASH Guidelines on use of anticoagulation in patients with COVID-19 being discharged from the hospital
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis
por: Riaz, Irbaz Bin, et al.
Publicado: (2023)

Comparison of health-related quality of life among patients using novel oral anticoagulants or warfarin for non-valvular atrial fibrillation
por: Balcı, Kevser Gülcihan, et al.
Publicado: (2016)

Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US
por: Eberly, Lauren A., et al.
Publicado: (2021)

Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial Fibrillation
por: Lin, Kueiyu Joshua, et al.
Publicado: (2023)

Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation
por: Schaefer, Jordan K., et al.
Publicado: (2022)

Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study
por: Ekblom, Kim, et al.
Publicado: (2005)

Senior volunteers: addressing loneliness in times of COVID-19
por: Torres, Zaira, et al.
Publicado: (2023)

Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US
por: Eberly, Lauren A., et al.
Publicado: (2021)

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
por: Fox, Keith A. A., et al.
Publicado: (2020)

Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 – Authors' reply
por: Lopes, Renato D, et al.
Publicado: (2021)

Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
por: Meinel, Thomas R., et al.
Publicado: (2023)

Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves
por: Steinberg, Zachary L., et al.
Publicado: (2017)

Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries
por: Wheelock, Kevin M., et al.
Publicado: (2021)

Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral Hemorrhage
por: Xian, Ying, et al.
Publicado: (2021)

Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2023)

Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19
por: Garibaldi, Brian T., et al.
Publicado: (2021)

Cost Conversations About Anticoagulation Between Patients With Atrial Fibrillation and Their Clinicians: A Secondary Analysis of a Randomized Clinical Trial
por: Kamath, Celia C., et al.
Publicado: (2021)

Evaluation of Preferred Language and Timing of COVID-19 Vaccine Uptake and Disease Outcomes
por: Quadri, Nasreen S., et al.
Publicado: (2023)

Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation
por: Derington, Catherine G., et al.
Publicado: (2023)

Association of COVID-19 With Achieving Time-to-Surgery Benchmarks in Patients With Musculoskeletal Trauma
por: Gitajn, Ida Leah, et al.
Publicado: (2021)

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study
por: Altay, Servet, et al.
Publicado: (2017)

Trends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010-2020
por: Iyer, Geetha S., et al.
Publicado: (2023)

Single-Bolus Tinzaparin Anticoagulation in Extended Hemodialysis Session: A Feasibility Study
por: Harvey, Benoît, et al.
Publicado: (2023)

Care in times of COVID-19: the impact of the pandemic on informal caregiving in Austria
por: Rodrigues, Ricardo, et al.
Publicado: (2021)

Association of Time to Surgery After COVID-19 Infection With Risk of Postoperative Cardiovascular Morbidity
por: Bryant, John M., et al.
Publicado: (2022)

Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US
por: Zheng, Zhe, et al.
Publicado: (2021)

Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage: A Systematic Review and Meta-analysis
por: Chaudhary, Rahul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6uor4cv7mjjsepk9qjtku10oue